23 June 2020: Clinical Research
The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis
Mei Tian 1BE* , Xiuchun Yang 1CD* , Yanfang Li 1BF , Sen Guo 2ABCDEFG*DOI: 10.12659/MSM.923359
Med Sci Monit 2020; 26:e923359
Table 1 Basic characters of patients with HCC.
| Characters | Number | Percentage |
|---|---|---|
| Sex | ||
| Female | 19 | 9.90% |
| Male | 173 | 90.10% |
| Age | ||
| 148 | 77.08% | |
| ≥60 | 44 | 22.92% |
| Tumor size (cm) | ||
| ≤5 | 98 | 51.04% |
| >5 | 94 | 48.96% |
| Tumor number | ||
| Single | 171 | 89.06% |
| Multiple | 21 | 10.94% |
| Histopathological grade | ||
| I+II | 123 | 64.06% |
| III | 69 | 35.94% |
| Vascular invasion | ||
| Negative | 127 | 66.15% |
| Positive | 65 | 33.85% |
| HBsAg | ||
| Negative | 50 | 26.04% |
| Positive | 142 | 73.96% |
| HCV | ||
| Negative | 179 | 93.23% |
| Positive | 13 | 6.77% |
| AFP | ||
| 109 | 56.77% | |
| ≥500 ng/ml | 83 | 43.23% |
| T stage | ||
| I | 72 | 37.50% |
| II | 67 | 34.90% |
| III | 49 | 25.52% |
| IV | 4 | 2.08% |
| Lymph invasion | ||
| Negative | 190 | 98.96% |
| Positive | 2 | 1.04% |
| TNM stage | ||
| I | 72 | 37.5% |
| II | 68 | 35.4% |
| III | 50 | 26.0% |
| IV | 2 | 1.0% |
| Dynamin 1 | ||
| Low | 113 | 58.85% |
| High | 79 | 41.15% |
| Dynamin 2 | ||
| Low | 135 | 70.31% |
| High | 57 | 29.69% |
| Dynamin 3 | ||
| Low | 176 | 91.67% |
| High | 16 | 8.33% |
| HBsAg – hepatitis B surface antigen; HCV – hepatitis C virus; AFP – alpha fetoprotein. | ||